BioFinlandin jäsen

AQ Biotech’s phage-biosensors represent cutting-edge technology for rapid, accurate, and affordable disease detection and monitoring. By leveraging the power of engineered phages and non-invasive biological sampling, the company seeks to renew the global healthcare diagnostics market and unlock the potential of personalized treatment response measurement.